Pharmacodynamics, Efficacy, and Safety of IPX203 in

website ipx 203 IPX203 is a novel, oral formulation of carbidopalevodopa extended-release capsules The drug is comprised of immediate-release ipx424 IPX-203 change from baseline scores for Movement Disorder Society - Unified Parkinson's Disease Rating Scale part III or sum of MDS-

ipx 203 IPX-203 was developed with an innovative formulation that contains immediate-release and extended-release granules, and mucoadhesive  Recently, Amneal Pharmaceuticals announced that the FDA has accepted for review the New Drug Application for IPX203 for the treatment of  DHIVY COMPONENT LEVODOPA; DIHYDROXYPHENYLALANINE; DOPA, L-; DOPAR; DOPASNAP COMPONENT LEVODOPA; DUOPA COMPONENT LEVODOPA; INBRIJA; IPX203 COMPONENT LEVODOPA

Share

Share

Link

Turn off sharing Copy link

See all details